Hepatitis Diagnostic Market

Global Hepatitis Diagnostic Market: Overview

An inflammation of the liver is called hepatitis. This condition can often lead to liver cancer, cirrhosis of liver, scarring or fibrosis in liver. Usually, a viral infection can cause hepatitis, however, there exists other possible causes of hepatitis as well. These comprise hepatitis that is caused by alcohol, toxins, drugs, or medications and autoimmune hepatitis. Increased prevalence the disease along with rising awareness about the disease is likely to foster growth of the global hepatitis diagnostic market over the timeframe of analysis, 2020 to 2030.

Diagnostic tests and region are the two important parameters based on which the global hepatitis diagnostic market has been classified.

Global Hepatitis Diagnostic Market: Notable Developments

A recent significant development that is anticipated to influence the future course of the global hepatitis diagnostic market is mentioned as below

• In March 2020, US-based Danaher Corporation acquired biopharma business of General Electric Company. The newly acquired business is expected to operate under the name of Cytvia. This acquisition is anticipated to expand the product portfolio of Danaher in the biopharma segment.

Some of the prominent organizations in the global hepatitis diagnostic market comprise the below-mentioned:

• Abbott Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Siemens AG
• DiaSorin S.p.A

Global Hepatitis Diagnostic Market: Key Trends

The global hepatitis diagnostic market is characterized by the presence of the following restraints, drivers, and opportunities.

Increased Level of Awareness and Availability of Advanced Tools to Boost Market Growth

Augmented awareness about this disease is generating mounting demand for its accurate detection. In addition to that, people are now more aware about the availability of options for treating hepatitis, which is likely to play an important role in fostering growth of the global hepatitis diagnostic market in the years to come,

Global Hepatitis Diagnostic Market: Geographical Analysis

North America is estimated to dominated the global hepatitis diagnostic market and account for a sizeable chunk of the total market revenue. The trend is likely to continue over the period of assessment, from 2020 to 2030. Growth of the North America market is ascribed to the presence of high awareness about the disease and its treatment options and availability of highly advanced diagnostic tools.